Stay updated with breaking news from Presight Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has launched an...
NEW YORK, NY, May 02, 2024 – Lindus Health, the “anti-CRO” running radically faster, more reliable clinical trials for life science pioneers, announced the results of a study examining the motivators and deterrents of clinical trial participation among ethnic minorities. The research paper, publish...
/PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has released a comprehensive...
NEW YORK, NY, Apr 2, 2024 – Lindus Health, the “anti-CRO” running radically faster, more reliable clinical trials for life science pioneers, has launched an all-in-one package of contract research organization (CRO) services specifically designed for clinical research into respiratory dis...
Get latest articles and stories on Business at LatestLY. Geneva [Switzerland], January 30: Transmutex SA, a nuclear engineering company based in Geneva, Switzerland, announces a new round of financing to further develop its solution for a safer, lower-cost, proliferation-resistant nuclear energy technology. The Series A2 round is co-led by Union Square Ventures and Steel Atlas. Business News | Geneva-based Transmutex SA, Raises over CHF 20M in Series A Extension to Further Develop and Commercialize Its Subcritical Nuclear Energy System.